MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 150 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $153,000 | +23.4% | 124,036 | +207.0% | 0.01% | +40.0% |
| Q1 2017 | $124,000 | -50.4% | 40,402 | -34.1% | 0.01% | -66.7% |
| Q4 2016 | $250,000 | -46.8% | 61,304 | -17.3% | 0.02% | -53.1% |
| Q3 2016 | $470,000 | +1205.6% | 74,116 | +984.2% | 0.03% | +1500.0% |
| Q2 2016 | $36,000 | -42.9% | 6,836 | -10.6% | 0.00% | -60.0% |
| Q1 2016 | $63,000 | -37.6% | 7,644 | -40.4% | 0.01% | -37.5% |
| Q4 2015 | $101,000 | +29.5% | 12,824 | +102.1% | 0.01% | +14.3% |
| Q2 2015 | $78,000 | – | 6,346 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |